{ "items": [ "\n\n
\n \n\n \n \n \n \n Research\n \n \n \n \n Stroke & Dementia\n \n \n\n \n\n\n
\n \n\n \n19 April 2022
\n \n \n \nThe only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n28 March 2022
\n \n \n \nA new DPAG-led review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n7 March 2022
\n \n \n \nThe \u00a33.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
\n \n\n \n \n\n \n\n \n \n \n \n Coronavirus\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n7 March 2022
\n \n \n \nResearchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n19 January 2022
\n \n \n \nResearchers from Oxford\u2019s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don\u2019t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.
\n \n\n \n \n\n \n\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n19 January 2022
\n \n \n \nAssociate Professor of Radiology, Godwin Ogbole has arrived on a six-month visit to the Nuffield Department of Clinical Neurosciences, as part of the Africa Oxford Initiative.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n7 January 2022
\n \n \n \nHuman-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n5 January 2022
\n \n \n \nA \u00a3210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.
\n \n\n \n \n\n \n\n \n \n \n \n Anaesthetics\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n17 December 2021
\n \n \n \nA proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n13 December 2021
\n \n \n \nScientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 December 2021
\n \n \n \nMany congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n19 November 2021
\n \n \n \nIn May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n11 November 2021
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n3 November 2021
\n \n \n \nMembers of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n27 October 2021
\n \n \n \nThe University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n27 October 2021
\n \n \n \nResearch reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n MRC BNDU\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n26 October 2021
\n \n \n \nA major new $9 million project funded by the Aligning Science Across Parkinson\u2019s (ASAP) initiative will map the original circuits vulnerable to Parkinson\u2019s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n12 October 2021
\n \n \n \nEye2Gene explores the use of AI to determine which genetic condition is causing a patient\u2019s inherited retinal disease, by examining eye scans.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 October 2021
\n \n \n \nMapping brain network activity from structural connectivity using deep learning
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n30 September 2021
\n \n \n \nResearchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in human consciousness.
\n \n\n \n \n